What Is Multiple Myeloma?
Multiple myeloma (MM), although rare (1), is the second most common blood cancer worldwide (2). It originates from bone marrow plasma cells, thus impacting regions where bone marrow is active, such as bones, blood, kidneys, and the immune system (2).
Multiple myeloma is complex, as it’s difficult to diagnose properly and has a complex guidelines schema (3, 4, 5). Cerba Research has you covered with a wide range of international multiple myeloma working group (IMWG) offerings that utilize cutting-edge techniques. As one of our sponsors said, “consistency of data can make or break an asset, which is why we prefer partnering with Cerba Research for MM IMWG testing.” Contact us to find out.

Multiple Myeloma